Eledon Pharmaceuticals, Inc. (ELDN)
Nasdaq · Pharmaceutical Preparations · Inc. DE
What they're doing
Not enough recent activity to summarise.
Signals, last 12 months
- Material 8-K filingFiled 8-K disclosing material agreement
Insider transactions
| Date | Insider | Role | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-31 | Gros David-Alexandre C | director | A | 354,454 | 0 | $0 |
| 2026-07-31 | Gros David-Alexandre C | director | F | 194,791 | 3.38 | $658,394 |
| 2026-07-31 | Perrin Steven | director | A | 152,353 | 0 | $0 |
| 2026-07-31 | Perrin Steven | director | F | 72,138 | 3.38 | $243,826 |
| 2026-01-10 | McBride John S. | director | M | 3,430 | 0 | $0 |
| 2026-01-10 | Hillson Jan | director | M | 3,430 | 0 | $0 |
| 2026-01-10 | Kirk Allan | director | M | 3,430 | 0 | $0 |
| 2026-01-10 | Katkin Keith | director | M | 8,575 | 0 | $0 |
| 2026-01-10 | Lee June | director | M | 3,430 | 0 | $0 |
| 2026-01-10 | Robinson James A. Jr. | director | M | 3,430 | 0 | $0 |
| 2026-01-10 | McBride John S. | director | M | 3,430 | 0 | $0 |
| 2026-01-10 | Hillson Jan | director | M | 3,430 | 0 | $0 |
| 2026-01-10 | Kirk Allan | director | M | 3,430 | 0 | $0 |
| 2026-01-10 | Katkin Keith | director | M | 8,575 | 0 | $0 |
| 2026-01-10 | Lee June | director | M | 3,430 | 0 | $0 |
| 2026-01-10 | Robinson James A. Jr. | director | M | 3,430 | 0 | $0 |
| 2024-05-09 | BVF PARTNERS L P/IL; BIOTECHNOLOGY VALUE FUND L P; BVF I GP LLC; BIOTECHNOLOGY VALUE FUND II LP; BVF II GP LLC; Biotechnology Value Trading Fund OS LP; BVF Partners OS Ltd.; BVF GP HOLDINGS LLC; BVF INC/IL; LAMPERT MARK N | ten percent owner | P | 1,031,385 | — | — |
| 2024-05-09 | BVF PARTNERS L P/IL; BIOTECHNOLOGY VALUE FUND L P; BVF I GP LLC; BIOTECHNOLOGY VALUE FUND II LP; BVF II GP LLC; Biotechnology Value Trading Fund OS LP; BVF Partners OS Ltd.; BVF GP HOLDINGS LLC; BVF INC/IL; LAMPERT MARK N | ten percent owner | P | 821,121 | — | — |
| 2024-05-09 | BVF PARTNERS L P/IL; BIOTECHNOLOGY VALUE FUND L P; BVF I GP LLC; BIOTECHNOLOGY VALUE FUND II LP; BVF II GP LLC; Biotechnology Value Trading Fund OS LP; BVF Partners OS Ltd.; BVF GP HOLDINGS LLC; BVF INC/IL; LAMPERT MARK N | ten percent owner | P | 75,431 | — | — |
| 2023-05-05 | BVF PARTNERS L P/IL; BIOTECHNOLOGY VALUE FUND L P; BVF I GP LLC; BIOTECHNOLOGY VALUE FUND II LP; BVF II GP LLC; Biotechnology Value Trading Fund OS LP; BVF Partners OS Ltd.; BVF GP HOLDINGS LLC; BVF INC/IL; LAMPERT MARK N | ten percent owner | P | 1,055,445 | — | — |
| 2023-05-05 | BVF PARTNERS L P/IL; BIOTECHNOLOGY VALUE FUND L P; BVF I GP LLC; BIOTECHNOLOGY VALUE FUND II LP; BVF II GP LLC; Biotechnology Value Trading Fund OS LP; BVF Partners OS Ltd.; BVF GP HOLDINGS LLC; BVF INC/IL; LAMPERT MARK N | ten percent owner | P | 837,146 | — | — |
| 2023-05-05 | BVF PARTNERS L P/IL; BIOTECHNOLOGY VALUE FUND L P; BVF I GP LLC; BIOTECHNOLOGY VALUE FUND II LP; BVF II GP LLC; Biotechnology Value Trading Fund OS LP; BVF Partners OS Ltd.; BVF GP HOLDINGS LLC; BVF INC/IL; LAMPERT MARK N | ten percent owner | P | 86,341 | — | — |
| 2022-11-23 | Perrin Steven | director | P | 1,000 | 2.6 | $2,597 |
| 2021-12-20 | Gros David-Alexandre C | director | P | 2,000 | 4.48 | $8,960 |
| 2021-08-17 | Gros David-Alexandre C | director | P | 4,000 | 6.21 | $24,840 |
| 2021-06-11 | Little Paul Sean | officer | P | 10,000 | 8.87 | $88,700 |
| 2021-06-09 | Gros David-Alexandre C | director | P | 3,000 | 8.01 | $24,030 |
| 2020-12-22 | BVF PARTNERS L P/IL; BIOTECHNOLOGY VALUE FUND L P; BVF I GP LLC; BIOTECHNOLOGY VALUE FUND II LP; BVF II GP LLC; Biotechnology Value Trading Fund OS LP; BVF Partners OS Ltd.; BVF GP HOLDINGS LLC; BVF INC/IL; LAMPERT MARK N | other | C | 15,166 | — | — |
| 2020-12-22 | BVF PARTNERS L P/IL; BIOTECHNOLOGY VALUE FUND L P; BVF I GP LLC; BIOTECHNOLOGY VALUE FUND II LP; BVF II GP LLC; Biotechnology Value Trading Fund OS LP; BVF Partners OS Ltd.; BVF GP HOLDINGS LLC; BVF INC/IL; LAMPERT MARK N | other | C | 654,215 | — | — |
| 2020-12-22 | BVF PARTNERS L P/IL; BIOTECHNOLOGY VALUE FUND L P; BVF I GP LLC; BIOTECHNOLOGY VALUE FUND II LP; BVF II GP LLC; Biotechnology Value Trading Fund OS LP; BVF Partners OS Ltd.; BVF GP HOLDINGS LLC; BVF INC/IL; LAMPERT MARK N | other | C | 11,278 | — | — |
| 2020-12-22 | BVF PARTNERS L P/IL; BIOTECHNOLOGY VALUE FUND L P; BVF I GP LLC; BIOTECHNOLOGY VALUE FUND II LP; BVF II GP LLC; Biotechnology Value Trading Fund OS LP; BVF Partners OS Ltd.; BVF GP HOLDINGS LLC; BVF INC/IL; LAMPERT MARK N | other | C | 509,410 | — | — |
| 2020-12-22 | BVF PARTNERS L P/IL; BIOTECHNOLOGY VALUE FUND L P; BVF I GP LLC; BIOTECHNOLOGY VALUE FUND II LP; BVF II GP LLC; Biotechnology Value Trading Fund OS LP; BVF Partners OS Ltd.; BVF GP HOLDINGS LLC; BVF INC/IL; LAMPERT MARK N | other | C | 1,944 | — | — |
| 2020-12-22 | BVF PARTNERS L P/IL; BIOTECHNOLOGY VALUE FUND L P; BVF I GP LLC; BIOTECHNOLOGY VALUE FUND II LP; BVF II GP LLC; Biotechnology Value Trading Fund OS LP; BVF Partners OS Ltd.; BVF GP HOLDINGS LLC; BVF INC/IL; LAMPERT MARK N | other | C | 97,615 | — | — |
| 2020-12-02 | OrbiMed Israel GP Ltd.; OrbiMed Israel BioFund GP Limited Partnership | ten percent owner | S | 103,200 | 21.6 | $2,229,120 |
| 2020-10-30 | Logos Global Management LP | ten percent owner | P | 5,000 | 24.03 | $120,163 |
| 2020-10-30 | Logos Global Management LP | ten percent owner | P | 31,000 | 24.53 | $760,427 |
| 2020-10-30 | Logos Global Management LP | ten percent owner | P | 4,000 | 25.97 | $103,892 |
| 2020-10-30 | Logos Global Management LP | ten percent owner | P | 15,000 | 26.48 | $397,236 |
| 2020-10-30 | Logos Global Management LP | ten percent owner | S | 12,942 | 26.64 | $344,829 |
| 2020-10-30 | Logos Global Management LP | ten percent owner | P | 12,942 | 25.88 | $334,926 |
| 2020-10-30 | Logos Global Management LP | ten percent owner | S | 27 | 27.02 | $730 |
| 2020-10-30 | Logos Global Management LP | ten percent owner | P | 15,000 | 26.17 | $392,610 |
| 2020-10-30 | Logos Global Management LP | ten percent owner | P | 9,098 | 25.55 | $232,460 |
| 2019-05-21 | TURKEL CATHERINE C. | officer | S | 1,914 | 1.91 | $3,658 |
| 2019-05-21 | Kuwahara Jon | officer | S | 1,058 | 1.91 | $2,022 |
| 2019-05-21 | FLESHER GREGORY J. | director | S | 2,937 | 1.91 | $5,614 |
| 2019-05-20 | TURKEL CATHERINE C. | officer | S | 7,623 | 1.96 | $14,953 |
| 2019-05-20 | Kuwahara Jon | officer | S | 4,218 | 1.96 | $8,274 |
| 2019-05-20 | FLESHER GREGORY J. | director | S | 11,701 | 1.96 | $22,953 |
| 2019-05-02 | OrbiMed Israel GP Ltd.; OrbiMed Israel BioFund GP Limited Partnership | director | P | 646,204 | 3.1 | $2,003,232 |
Federal contracts
No federal contract actions on record for this recipient mapping.
Lobbying
No federal lobbying filings on record for this client mapping.
Public attention
No Wikipedia pageview data linked to this company.
Recent filings
- 2026-09-04 S-8
- 2026-08-13 10-Q
- 2026-08-13 8-K
- 2026-08-04 4
- 2026-08-04 4
- 2026-07-31 SCHEDULE 13G
- 2026-06-22 8-K
- 2026-05-15 SCHEDULE 13G/A
- 2026-05-13 10-Q
- 2026-05-13 8-K
- 2026-05-11 EFFECT
- 2026-05-07 CORRESP
- 2026-05-07 UPLOAD
- 2026-05-01 S-3
- 2026-04-30 DEFA14A
- 2026-04-30 ARS
- 2026-04-30 DEF 14A
- 2026-04-21 PRE 14A
- 2026-03-26 SCHEDULE 13G/A
- 2026-03-19 10-K